An early pilot trial suggests that combining atezolizumab (tecectriq) with rituximab (Rituxan), gemcitabine (gemzar) and ...

In the ECHELON-3 study, the brentuximab vedotin combination with lenalidomide and rituximab reduced mortality risk by 37% compared with placebo.

Patients with SMZL often experience lymphocytosis and cytopenias, such as anemia and thrombocytopenia ... only radiotherapy or surgical resection without additional management, rituximab as ...

At the moment CAD is managed using off-label therapies, including rituximab and corticosteroid ... other indications including immune thrombocytopenic purpura. Last year, Sanofi recorded late ...

Life-threatening involvement (LTI) included renal involvement (according to the 2019 ACR/EULAR SLE criteria), haematological involvement (serum platelet levels < 100.000/mm 3, thrombotic ...

Expert Rev Clin Immunol. 2009;5(4):381-390. Several intravenous and subcutaneous Ig (SCIg) preparations are available either in a lyophilized form or as ready-to-use solutions. These products ...

Knowing what to ask your doctor about your CLL treatment can help you feel more comfortable with your diagnosis and know what to expect for the future. There are many treatment options, each ...

The addition of pirtobrutinib to the treatment regimens played a role in controlling the disease after previous therapeutic failures. Promising outcomes were achieved ...

After hours: March 14 at 7:31:58 PM EDT Loading Chart for ITP ...

increased risk of some cancers B-cell inhibitors Belimumab and rituximab Infusion reactions, increased risk of serious infections, reactivation of viral infections Interleukin inhibitors Anakinra, ...